Every hour there is a plane in the air, a ship on the seas or a truck on the road delivering Teva’s generic medicines to pharmacies and hospitals around the world. That’s why a substantial part of our business today and a significant portion of our research and development budget is focused on generic medicines.

Around 200 million people worldwide take one of our medicines every day. Our global footprint is critical to ensuring that patients have access to quality generic medicines - to help manage disease, fight infection, or simply improve overall health.

Teva has the largest supply chain of any pharmaceutical company and our network of about 37,000 employees and 58 global manufacturing sites work around the clock to make sure our medicines reach patients and healthcare systems across six continents. In addition, many prescription medications made by other companies include active pharmaceutical ingredients produced by Teva.

We are committed to creating quality, affordable medicines for more people in more places around the world. Our scientists are currently developing hundreds of generic medicines that aim to increase access to treatments that can improve patients’ health and save healthcare providers billions. Teva continues to strive for a healthier world.